gptkbp:instanceOf
|
gptkb:company
|
gptkbp:annualReport
|
https://www.boiron.com/en/investors/financial-information/
|
gptkbp:CEO
|
gptkb:Valérie_Lorentz-Poinsot
|
gptkbp:competitor
|
gptkb:Schwabe
gptkb:Weleda
Heel
|
gptkbp:controversy
|
criticized for lack of scientific evidence for homeopathy
|
gptkbp:country
|
gptkb:France
|
gptkbp:focus
|
homeopathic remedies
|
gptkbp:founded
|
1932
|
gptkbp:founder
|
gptkb:Henri_Boiron
gptkb:Jean_Boiron
|
gptkbp:hasChair
|
Thierry Boiron
|
gptkbp:headquartersLocation
|
gptkb:Messimy,_France
|
https://www.w3.org/2000/01/rdf-schema#label
|
Boiron SA
|
gptkbp:industry
|
pharmaceuticals
homeopathy
|
gptkbp:ISIN
|
FR0000061129
|
gptkbp:legalForm
|
Société Anonyme
|
gptkbp:listedOn
|
gptkb:Euronext_Paris
|
gptkbp:listedSince
|
1987
|
gptkbp:market
|
global
|
gptkbp:memberState
|
over 50
|
gptkbp:notableProduct
|
gptkb:Oscillococcinum
gptkb:Arnica_montana
Camilia
Coldcalm
Coryzalia
Homeovox
Roxalia
|
gptkbp:numberOfEmployees
|
~3000
|
gptkbp:operatesIn
|
over 50 countries
|
gptkbp:parentCompany
|
gptkb:Boiron_Group
|
gptkbp:products
|
gptkb:Oscillococcinum
homeopathic medicines
|
gptkbp:publiclyTraded
|
yes
|
gptkbp:regulates
|
faced regulatory scrutiny in several countries
|
gptkbp:revenue
|
€534 million (2022)
|
gptkbp:SIREN
|
572072246
|
gptkbp:SIRET
|
57207224600013
|
gptkbp:stockExchange
|
gptkb:Euronext_Paris
|
gptkbp:stockSymbol
|
gptkb:BOI
|
gptkbp:subsidiary
|
gptkb:Boiron_USA
Boiron Brazil
Boiron Canada
Boiron Italy
Boiron Mexico
|
gptkbp:website
|
https://www.boiron.com/
|
gptkbp:bfsParent
|
gptkb:Boiron_Group
|
gptkbp:bfsLayer
|
8
|